Doccla, a London, UK-based virtual ward and patient monitoring technology company, raised £15M in Series A funding.
The round was led by General Catalyst, with participation from KHP Ventures, Giant Ventures, and Speedinvest. In conjunction with the funding, Chris Bischoff, Managing Director at General Catalyst, will be joining the board.
The company intends to use the funds for the development of a tech stack that facilitates the integration of its patient monitoring solutions with more medical devices and electronic healthcare record systems, data analytics and AI, as well as expand clinical capacity and availability in order to meet the demand for virtual hospitals that alleviate pressures on healthcare systems. Doccla also anticipates forthcoming expansion to new European markets and segments.
Founded in Sweden in 2019 by health and tech entrepreneurs, Martin Ratz and Dag Larsson, Doccla provides a comprehensive remote patient monitoring service which allows clinical staff from hospitals across the UK to monitor the vital signs of those under treatment remotely, either continuously or intermittently.
The offering consists of a tailor-made box of equipment, which includes pre-configured smartphones that have a large font that is easier to read for those with vision impairments, and wearable medical devices that can measure a wide range of physiological parameters such as heart rate, respiration rate, body temperature, sp02, and blood pressure.
The solution is device agnostic, integrates with local systems, and delivers data driven insights. As an accredited healthcare operator, they provide additional clinical capacity – not just technology – to reduce hospital workload.
Current clients include a number of NHS trusts across the country, including Northampton General Hospital, Cambridgeshire Community Services, and Hertfordshire Community Trust.
FinSMEs
29/09/2022